Avanos Medical, Inc., headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for pain management and surgical care. Founded in 2014, the company has rapidly established itself as a leader in its field, focusing on advanced technologies that enhance patient outcomes and streamline healthcare processes. With a diverse portfolio that includes products for pain management, wound care, and respiratory health, Avanos Medical distinguishes itself through its commitment to quality and innovation. The company operates in key regions across North America and Europe, ensuring a broad reach in delivering its unique offerings. Notable achievements include significant advancements in regional anaesthesia and the development of proprietary devices that improve procedural efficiency. Avanos Medical continues to solidify its market position by prioritising patient-centric solutions and fostering strong partnerships within the healthcare community.
How does Avanos Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Avanos Medical, Inc.'s score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Avanos Medical, Inc. reported total carbon emissions of approximately 11,695,770 kg CO2e. This figure includes Scope 1 emissions of about 229,240 kg CO2e and Scope 2 emissions of approximately 11,466,530 kg CO2e. Notably, there are no disclosed Scope 3 emissions in the available data. Currently, Avanos Medical has not set specific reduction targets or initiatives, nor have they made any climate pledges. This lack of formal commitments may reflect the broader industry context, where many companies are increasingly focusing on sustainability and carbon reduction strategies. As a company headquartered in the US, Avanos Medical's emissions data highlights the need for ongoing evaluation and potential enhancement of their climate commitments in line with global sustainability trends.
Access structured emissions data, company-specific emission factors, and source documents
Get Started2021 | |
---|---|
Scope 1 | 229,240 |
Scope 2 | 11,466,530 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avanos Medical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.